# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
1 | 04-01-2024 | 12-31-2023 | 10-K |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
TC BioPharm (Holdings) plc ("TC BioPharm" or the "Company") (NASDAQ:TCBP), a clinical stage biotechnology compa...
EYPT: -42% | EyePoint Pharmaceuticals shares are trading lower after the company's Phase 2 PAVIA trial of DURAVYU did not m...
Acquisition target has established proof of concept data demonstrating the therapeutic potential for the treatment of multiple ...
Shares of Reliance Global Group, Inc. (NASDAQ: RELI) fell sharply in today’s pre-market trading after reporting financial res...